AU · biotech · cancer · radiotherapy
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series C · Feb 2025 · $112M
Sanofi Ventures lead, Abingworth lead, SymBiosis lead, SV Health Investors lead, Brandon Capital, Morningside, Tenmile
Reported by Startup Daily
Missing a round, or an investor who was in one? Tell us.